Yang Liu

Dr. Yang Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Open Life Sciences
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
HHHuiqin Hao
Huiqin Hao
THTiezheng Hou
Tiezheng Hou
The concanavalin A (Con A)-induced liver injury mouse model is a typical animal model focusing on T cell-dependent hepatic damage in the field of autoimmune hepatitis (AIH). However, the underlying mechanism of hepatic dysfunction due to cell activation or signaling pathways triggered by Con A has not been fully clarified. Therefore, the controversy on this model remains in the academic community. In this article, we first summarized the merit and demerit of this contentious model from the perspectives of cell dysfunction, microcirculation disturbance, involved signaling pathways, as well as the properties of Con A. Then, we summed up the scientific implications of the model in elucidating the pathogenesis of AIH, and the shortcomings of this model were also summarized to elucidate the pathogenesis and application prospect of this classical liver injury mouse model in the study of AIH.

11 March 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YZYumeng Zhang
Yumeng Zhang
HJHaizhu Jin
Haizhu Jin
WJWenyue Jia
Wenyue Jia
YLYuqi Liu
Yuqi Liu
YWYuru Wang
Yuru Wang
HHHuiqin Hao
Huiqin Hao

24 April 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
TBTe Ba
Te Ba
RNRui Niu
Rui Niu
JGJianjun Gao
Jianjun Gao
WLWenfang Li
Wenfang Li
MDMengwei Dong
Mengwei Dong
NLNingcen Li
Ningcen Li
Stroke-induced cognitive impairment is a common complication and an important risk factor for disability. Prevention and treatment of secondary stroke injuries are crucial. Modern research has found that the gut microenvironment can directly or indirectly affect neurological function and cerebral ischemic outcomes, and their crosstalk is achieved through the microbiota-gut-brain-axis (MGBA). Acupuncture, as a promising non-drug treatment, has been recommended for improving post-stroke cognitive impairment (PSCI). However, in recent years, few studies have systematically analyzed the potential mechanisms in this field, and whether acupuncture can improve PSCI through the MGBA remains to be explored. This review comprehensively summarizes literature and shows that, acupuncture, as an adjuvant therapy can play a potential important role in the treatment of PSCI by regulating the microbiota-gut-brain-axis. Acupuncture can repair intestinal epithelial barrier, regulate gut microbiota and serum metabolites, alleviate gut inflammation and neuroinflammation, and regulating HPA axis function, etc. From the studies we have included, the evidence for its effectiveness remains limited, these results should be interpreted with caution due to the low quality of evidence. Future high-quality clinical and experimental studies are needed. This review also discussed the development prospects of acupuncture in improving PSCI via the MGBA, such as genomics, personalized therapy, establishment of standards, and combination therapy, etc. providing new research ideas and scientific and reliable evidence for the application of acupuncture in PSCI.

13 November 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JWJiawen Wu
Jiawen Wu
SLSixue Lyu
Sixue Lyu
DGDi Guo
Di Guo
NYNa Yang
Na Yang
YLYang Liu
Yang Liu
Background: Autoimmune hepatitis (AIH) is a chronic liver inflammatory disease mediated by autoimmune reactions, the pathogenesis of AIH is probably related to the imbalance of intestinal flora. Yinchenhao decoction (YCHD) has been used to relieve AIH. However, the mechanisms underpinning YCHD’s hepatoprotective effects with the gut microbito have not been fully revealed.Objective: To explore the potential mechanism of YCHD in treating AIH based on changes in the intestinal flora and Th1/Treg ratio in the spleen and hepatic hilar lymph nodes.Methods: The AIH mice model induced by the adenovirus vectors that overexpress human cytochrome P450 family 2 subfamily D member 6 (Ad-CYP2D6) was established (untreated group). One week after the Ad-CYP2D6 injection, the AIH model mice were treated by administering YCHD by gavage for 14 days (YCHD-treated group). The therapeutic efficacy of YCHD on AIH was evaluated by detecting the histopathological changes of the liver, serum transaminases (ALT and AST), inflammatory factors (TNF-α,IL-17 and IFN-γ), and autoantibodies (including LKM-1 and LC-1). The ratio of Th1 to Treg within the spleen and hepatic hilar lymph nodes of the mice was detected by flow cytometry. The changes in the species and abundance of intestinal flora and intestinal flora metabolites were analyzed via 16S rRNA gene sequencing and gas chromatography-mass spectrometry (GC/MS) to reveal the protective mechanism of YCHD on liver injury.Result: YCHD decreased the transaminase activity (AST and ALT), the content of autoantibodies (LC-1 and LKM-1), and the serum TNF-α, IL-12, and IL-17 levels in AIH mice. The degree of inflammatory infiltration in the YCHD-treated group was significantly less than that in the untreated group. YCHD can effectively reverse the abundance and diversity of intestinal flora in AIH mice and affect the release of short-chain fatty acids (SCFAs), especially butyric acid. Moreover, the flow cytometry results showed that YCHD could also decline the ratio of Th1/Treg, which probably be induced by SCFAs via the G protein-coupled receptor (GPR).Conclusion: YCHD may affect the release of SCFAs by regulating the intestinal microbiota, thereby affecting the differentiation of Th1 and Treg, and achieving the effect of alleviating liver damage.

31 October 2022 in Food & Function
Verified
Journal Article
Closed access
PDF file
YZYumeng Zhang
Yumeng Zhang
YLYang Liu
Yang Liu
FPFei Peng
Fei Peng
XWXinrui Wei
Xinrui Wei
HHHuiqin Hao
Huiqin Hao
YZYuqing Zhao
Yuqing Zhao
The imbalance of intestinal flora would induce immune inflammation. Cedrol (CE), found from ginger by our group earlier, has been proven to play an excellent role in ameliorating rheumatoid arthritis (RA) via acting on JAK3, MAPK, and NF-κB. However, there have been no studies on CE ameliorating RA through the regulation of the micro-environment. In this study, the adjuvant arthritis model (AIA) is established to evaluate the weight, arthritis score, paw swelling, bone destruction, immune organ index, inflammatory cell infiltration, cartilage erosion, and metabolic enzymes of kidneys in AIA rats after CE intervention. The results indicated CE could alleviate paw swelling, reduce arthritis score, decrease the secretion of TNF-α, IL-6, and IL-1β in serum in a dose-dependent manner, and inhibit the immune organ index of the spleen while having no significant effect on metabolic enzymes of the kidney. In addition, pathological sections of ankle and knee joints suggested CE might significantly prevent inflammatory cell infiltration, synovial hyperplasia, and joint degeneration and protect articular cartilage. Then, for the first time, 16S rRNA gene was applied to analyze the regulatory effect of CE on intestinal flora. CE could effectively improve the uniformity, diversity, and richness of intestinal flora, reduce the number of pathogenic bacteria, and increase the proportion of beneficial bacteria, and it significantly inhibited the abundance of Prevotella in RA rats, which was 12.43 times smaller than that in methotrexate. The distribution and excretion of CE in vivo were detected by GC-MS. It was found that CE would massively accumulate in the gastrointestinal tract after oral administration, which is then mainly excreted through feces. Interestingly, the research suggested that CE, which plays a role in the dynamic regulation of the intestinal micro-environment, could be used as a potential component to prevent RA.

27 May 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
JKJunfeng Kang
Junfeng Kang
LZLu Zhang
Lu Zhang
NNNan Nan
Nan Nan
YLYang Liu
Yang Liu
HHHuiqin Hao
Huiqin Hao